chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms: coughing, runny nose, sinus pain and pressure, sore throat. After a week and a half the symptoms got worse. Had a fever just one day. Decided to go to the clinic. I was diagnosed with a sinus infection and prescribed Amoxicillin in pill form. It took a couple weeks after that before I felt better. But cough lingered a while longer.
pt recv vax 27SEP96 & 28SEP96 pt devel swelling of uvula;
Patient is experiencing daily headaches since her vaccine. She describes the intensity staying the same or possibly worsening since it has been almost 2 weeks since her vaccine. She has tried Naproxen which helps a little to "take the edge off" and tried a gel eye mask. She describes the headaches as dull and hurting a lot behind the eyes. She is also experiencing a mild aching pain in her joints.
Hives that itch and burn all over my body that disappear and come back within hours. This is first time I have broken out in hives. Diet and environment are unchanged. I?m on immunosuppressants I don?t know if this would effect or be related to my hives. I?m on day 3 of having them and I?m not sure if it?s related to the vaccine.  My doctor prescribed a weeks worth of steroids to see if it would have any affect of the hives.
Hypotension s/s post tetanus immunization. S/S included: auditory disturbance, lightheadedness, dizziness, pale skin, sweating, visual disturbance, and weakness. Donor received 500 ml procedural saline, oral fluids, and monitored vitals. After discussion, donor stated she hadn't ate enough prior to that day's donation and immunization.
COLDNESS; CHILLS; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on right arm on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-MAR-2021, the subject experienced coldness. On 19-MAR-2021, the subject experienced chills. On 19-MAR-2021, the subject experienced weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from weakness on MAR-2021, had not recovered from chills, and the outcome of coldness was not reported. This report was non-serious.
Patient got dose #2 of vaccine on  02APR21 at 1552.  At 1740, patient complained of headache, dizziness, nausea and warm to touch.  He laid down on a cot, had snacks and water.  B/P 136/69, HR 70, O2 sat. 97%.  He was observed by an RN for an additional 30 minutes before sitting up for 10-15 minutes at which time he stated he felt better.  At 2000, he returned to the vaccine room complaining of nausea and extreme fatigue.  He was given Benadryl 25 mg po.  O2 sat. 98%, HR 94.  Patient sent home.
This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. There was no information regarding the patient's medical history, concomitant medications, drug reactions or allergies provided. On 08-OCT-2018, the patient was vaccinated with M-M-R II (lot# N032757; expiration date: 20-NOV-2019; therapy type: rHa) and with VARIVAX (lot# M041514; expiration date: 11-OCT-2018), both via intramuscular route for prophylaxis. No adverse event was reported.
Pt recvd 3 doses of Engerix-B & 5AUG92 HBSAB titer was neg; may receive addtl vax doses;
Paresthesias, on lower extremities and tingling on right arm all day; intermittent numbness; right eye twitching daily; This is a spontaneous report from a contactable healthcare professional (patient). A 40-year-old female patient received the second dose of BNT162B2 (lot number: EG686), intramuscularly in left arm on 12Jan2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously took tramadol and experienced drug allergy, and the first dose of BNT162B2 (lot number: GK5730) in left arm for COVID-19 immunisation. The patient experienced parethesias, on lower extremities and tingling on right arm all day, intermittent numbness, right eye twitching daily on 15Jan2021. The patient underwent lab tests and procedures which included nasal swab, COVID test result: Negative on an unspecified date. AE resulted in: Doctor or other healthcare professional office/clinic visit. No treatment received for these events. Patient was not recovered.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11Feb2023. She confirmed 8 doses were given after 11Feb2023. Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (vial size was initially stored in the refrigerator on 12-Jan-2023 and vaccine was administered on 11-Feb-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.     No treatment medications were reported.  This case contains information for the 1st of 8 adult patients described by the reporter.
I tested positive for COVID on 12/30.  Re-tested on 01/2/8 and results were negative.   I asked when I checked in to get the first dose of the vaccine if I should take it now or wait a little longer.  They told me it was OK to take.  I received it around noon on 2/5 and arm was a little sore that evening but expected.  However on 2/6 when I got up my arm was extremely sore which I could deal with but the rest of me felt like I had COVID again.   I had the nauseated feeling, body aches, headaches, lack of appetite and extremely fatigue just like the first day of COVID on 12/30.   This continued until around 7pm the following day on 2/7 before I started feeling better.   Today is 2/8 and I still have a little bit of a headache  but feeling much better.   I was going to be retested if I felt as bad as I did on 2/6 and 2/7.   I did not go to the doctor since it was the weekend and no way did I want to go to the ER.
Briusing at injection site, day 2. Redness Size of baseball, Bruising approx. 2 inch diameter, day 3, mild soreness, area warm to touch.
first shot did hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR122410   Additional Information: GSK Receipt Date: 17-AUG-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The first shot was regular one that did hurt patient. The reporter called pharmacy in their area and asked them what would be the cost if the age was under 60. Additional Supportive Information: For tolerance to the 2nd dose refer US2022AMR122410.; Sender's Comments:  US-GSK-US2022AMR122410:same report, other dose
experiencing Tinnitus every time he takes the vaccine/with each new vaccine the tinnitus gets a little bit louder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 70-year-old male patient received BNT162b2 (BNT162B2), on 31Mar2021 as dose 2, single (Lot number: ER8733) for covid-19 immunisation. The patient's medical history, reported also as family history included: "Hearing loss" (ongoing), notes: has hereditary hearing loss and tinnitus, the ringing in the ears; "Tinnitus" (unspecified if ongoing), notes: has hereditary hearing loss and tinnitus, the ringing in the ears. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "Tinnitus". The following information was reported: TINNITUS (non-serious), outcome "not recovered", described as "experiencing Tinnitus every time he takes the vaccine/with each new vaccine the tinnitus gets a little bit louder".  Additional information: The reporter stated that the patient had the original two vaccine shots and two boosters from Pfizer but not the bivalent one. The reporter mentioned that the patient has hereditary hearing loss and tinnitus, the ringing in the ears, and with each new vaccine the tinnitus gets a little bit louder. It was reported that it does not come back down, it stays in an elevated level, it has happened every time. The reporter asked how to approach this, if the patient can continue the vaccine, if it will make the tinnitus even louder, and what was causing the patient to have tinnitus.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (15Aug2023): This is a spontaneous follow-up report from a contactable consumer. This consumer (Wife) reported for a 70- Years-Old Male patient (Husband). Updated information included: Reporter information, patient information (Age, unit, weight, height and race added), dosage regimen (Start date, stop date, lot number added) and vaccination facility information (Vaccination facility name, city, state and Vaccine Administered at Facility? Added).; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300276720 same reporter/patient/suspect vaccine/event; different dose;US-PFIZER INC-202300276920 same patient/reporter/AE, different dose;
Your child received a vaccination at our clinic during the period between February 28 and April 16, 2020. During the period between February 28th, 2020 and March 2nd, 2020, our data logger had a technical malfunction that we were not aware of and it stopped sending its temperature recordings to the system. During that period the fridge never stopped working. The temperature logs of the fridge before and after the incident were always within required range. Our fridge has been always in a perfect new condition and never had any temperature problems previously. There was no power outage in the area or inside the office during that period as well.    The CDC requires continuous temperature monitoring of all VFC vaccines and due to lack of continuous temperature data documentation, the vaccine manufacturers have determined that the doses administered on these dates should be re-administered to ensure proper effectiveness.
Site red & warm. C/O chest pains. Went to PMD had EKG done > abnormal. Chest x-ray ordered. Going to see cardiologist. Not sure if related to GARDASIL or not.
pt recv vax  6MAR96 & 15MAR96 pt exp elevated ALT;
Vaccination medication administration error.  After vaccinator injected the vaccine, vaccinator pulled out the syringe without pushing the safety. Vaccinator pushed the safety once it was out of the arm and fluid from the syringe went to the vaccinators eye.  Vaccinator washed the affected eye and contact lens and put it back on the eye. Vaccinator notified leadership and was instructed to wash eye for at least 15 minutes. Vaccinator removed contacts and washed eye as instructed. Did not put contacts back on.  Pt and vaccinator was instructed to wait to be tested and go to an urgent care.  Vaccinator denies vision changes or vision pain.
lightheaded, sl nauseated lasted <40min;pt feels sx were d/t nervousness;sx disappeared w/no tx;
lymphadenopathy-golf ball size-in lt axilla; 2DEC93 no response to f/u request;
I am experiencing bone and joint pain. The effects are concentrated in my knees.; I am experiencing bone and joint pain. The effects are concentrated in my knees.; I am experiencing bone and joint pain. The effects are concentrated in my knees.; This is a spontaneous report from a contactable consumer. This 48-year-old non-pregnant female consumer (patient) reported that she received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: GW0183) via an unspecified route of administration on 14Jun2021 (at 48-year-old) on left arm as dose number unknown, single for COVID-19 immunization. The patient had no medical history and no allergies. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient's concomitant medications were not reported. It was mentioned that patient was not pregnant at the time of vaccination, she did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. On 14Jun2021 at 04:30 PM the patient experienced bone and joint pain. The effects are concentrated in her knees. No treatment was received for the events..The patient had not recovered. The device Date was 21Jun2021 Follow-up attempts were completed. No further information was expected.
Shaking; Weakness; affect balance; temperature; Chilly; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking), ASTHENIA (Weakness), BALANCE DISORDER (affect balance), PYREXIA (temperature) and CHILLS (Chilly) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in June 2020.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TREMOR (Shaking), ASTHENIA (Weakness), BALANCE DISORDER (affect balance), PYREXIA (temperature) and CHILLS (Chilly). At the time of the report, TREMOR (Shaking), ASTHENIA (Weakness), BALANCE DISORDER (affect balance), PYREXIA (temperature) and CHILLS (Chilly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant details not reported by the reporter. Treatment details not reported by the reporter.
Patient received ZOSTAVAX and that night had chest pains and fever 102.  He has myalgias also.  By the morning he was "fine"
expired pen was administered to a patient and received vaccine which they believe was expired upon receipt. That dose was later given to a patient with no AE; Initial information received on 14-Oct-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age patient who was vaccinated with an expired dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of expired vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE, (lot: UI871AB and expiry date: 11-May-2018) via unknown route used for prophylactic vaccination.  It was a case of expired vaccine used.  At the time of the report, no adverse event was reported.   Disclaimer: this suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in directive 2001/83/ec and module VI of the good pharmacovigilance practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  No further relevant information was reported.
Left arm injection. Read and white (left arm) Sore (left arm) Bruised injection site Diarrhea Fatigue
Initial vaccine (3/31/2021) and booster (11/13/2021) produced the same side effects. Very painful headache, significant body aches all over, post nasal drip/runny nose, chills, mild fever (only for a few hours at start of symptoms), pain at injection site with mild swelling, fatigue. Symptoms usually begin 8-10 hours after vaccine and last for 3-6 days. The worst part is the pain and fatigue, which could be a flare up of fibromyalgia symptoms at some point. Currently recovering from booster dose.
There is still (as of today 10/3/2013) slight yellow / blue discoloration around the area of the injection and the arm still hurts.
Developed chest pain approximately 30 hours later as well as pressure. Described as feeling like a heart attack.  Went to local ER approximately 48 hours following the vaccination.  Completed labs, X-ray, and EKG. Transferred from local ER  to nearest hospital ER.  Labs, X-ray, and EKG were completed again.  Spent approximately 12 hours in both ERs. Admitted to the step-down cardiac unit to monitor. Labs, X-ray, and EKG again. Discharged approximately 10 hours later.
4/2/2021 vaccination site swollen, red & itchy. 4/6/2021 itchy rashes on the front & back right side of my ribs, resembles shingles. Not painful, just extremely itchy. I still have the rash today 4/8.
can the blood thinner with the vaccine cause a nosebleed; nosebleed off and on since [he] got the first dose; This is a spontaneous report from a contactable consumer or other non hcp. A 79-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown) via an unspecified route of administration on an unspecified date as dose, single for COVID-19 immunisation. Medical history included blood disorder. On an unspecified date the patient experienced "nosebleed off and on since [he] got the first dose, and "can the blood thinner with the vaccine cause a nosebleed. Patient stated that he got both doses of the Pfizer-BioNTech COVID-19 vaccine. He explained he had a "nosebleed off and on since [he] got the first dose", and he specified he "never had this before". He added he is on a blood thinner. He asked can the blood thinner with the vaccine cause a nosebleed. The outcome of the event was unknown.   No follow up attempts are possible; information about lot/batch number cannot been obtained.
afternoon of shot child had episode of high pitched, inconsolable crying lasting 20min;mom went to ER;child adopted from Russia-prev hx unk;
AUTOIMMUNE DISORDER; BILATERAL INFILTRATES; This spontaneous report received from a physician concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient did not have autoimmune disorder prior to receiving the Janssen covid-19 vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced autoimmune disorder and bilateral infiltrates and visited emergency room. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The outcome of the autoimmune disorder and bilateral infiltrates was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210451619-covid-19 vaccine ad26.cov2.s-autoimmune disorder. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
soreness in arm; It's over 45 days from first dose of vaccine; fatigue; Tested positive with COVID-19; A Spontaneous report  was received by a consumer concerning a male patient of 90 years of age, who received Moderna's COVID-19 vaccine on 29 Jan 2021 and experienced Soreness in the arm, Fatigue, Covid-19 positive result and Product dose omission issue on various known and unknown dates.  The patient's medical history was unknown. Concomitant product use was not provided by the reporter.  On 29 Jan 2021, prior to the onset of events, the patient received a dose of mRNA-1273 (lot number - 032L20A) via intramuscular route for COVID-19 infection prophylaxis.  On an unknown date, after dose of vaccine, the patient experienced Soreness in the arm, Fatigue, Product dose omission issue.  On 19 Feb 2021 , after the dose of vaccine the patient experienced Covid-19 positive result.   Treatment medication was not reported by the reporter .  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event, Soreness in the arm, Fatigue, Covid-19 positive result and Product dose omission issue was considered to be unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, Pain in extremity, Fatigue and Covid-19, a causal relationship cannot be excluded.  This report also refers to a case of Product dose omission issue, for mRNA-1273, lot #: 032L20A.
fever-4Mar & 6Mar. feels achy, rash-8Mar red, fine, patchy distribution, hands, arms, legs, neck
red lump; black and red bruising; red; upper arm is still bruised; hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (upper arm is still bruised), VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE BRUISING (black and red bruising), VACCINATION SITE MASS (red lump) and VACCINATION SITE ERYTHEMA (red) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O13L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE BRUISING (upper arm is still bruised), VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE ERYTHEMA (red). On 27-Jan-2021, the patient experienced VACCINATION SITE BRUISING (black and red bruising). On an unknown date, the patient experienced VACCINATION SITE MASS (red lump). At the time of the report, VACCINATION SITE BRUISING (upper arm is still bruised), VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE ERYTHEMA (red) outcome was unknown, VACCINATION SITE BRUISING (black and red bruising) had not resolved and VACCINATION SITE MASS (red lump) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient did not receive any treatment. Reportedly, the patient denied bumping against anything.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: NNI-TCR (reporter provided email address)